- Home
- FSK vs INSP Comparison
FSK vs INSP Comparison
Compare FSK & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSK
- INSP
- Stock Information
- Founded
- FSK 2007
- INSP 2007
- Country
- FSK United States
- INSP United States
- Employees
- FSK N/A
- INSP N/A
- Industry
- FSK Investment Managers
- INSP Medical/Dental Instruments
- Sector
- FSK Finance
- INSP Health Care
- Exchange
- FSK Nasdaq
- INSP Nasdaq
- Market Cap
- FSK 6.0B
- INSP 5.6B
- IPO Year
- FSK N/A
- INSP 2018
- Fundamental
- Price
- FSK $21.30
- INSP $187.83
- Analyst Decision
- FSK Hold
- INSP Buy
- Analyst Count
- FSK 9
- INSP 11
- Target Price
- FSK $20.00
- INSP $232.55
- AVG Volume (30 Days)
- FSK 1.6M
- INSP 461.9K
- Earning Date
- FSK 11-06-2024
- INSP 02-04-2025
- Dividend Yield
- FSK 13.15%
- INSP N/A
- EPS Growth
- FSK N/A
- INSP N/A
- EPS
- FSK 1.89
- INSP 1.09
- Revenue
- FSK $1,761,000,000.00
- INSP $755,594,000.00
- Revenue This Year
- FSK N/A
- INSP $29.96
- Revenue Next Year
- FSK N/A
- INSP $19.52
- P/E Ratio
- FSK $11.29
- INSP $171.71
- Revenue Growth
- FSK N/A
- INSP 32.52
- 52 Week Low
- FSK $18.31
- INSP $123.00
- 52 Week High
- FSK $22.39
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- FSK 49.67
- INSP 47.35
- Support Level
- FSK $20.94
- INSP $181.85
- Resistance Level
- FSK $21.49
- INSP $198.33
- Average True Range (ATR)
- FSK 0.28
- INSP 7.37
- MACD
- FSK -0.08
- INSP -0.22
- Stochastic Oscillator
- FSK 30.51
- INSP 36.29
About FSK FS KKR Capital Corp.
FS KKR Capital Corp is a business development company based in the United States. Its portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies. It is focused on providing customized credit solutions to private upper middle-market companies, which it generally defines as companies with annual EBITDA of at least $50 million at the time of investment.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.